Rivastigmine for Intensive Care Unit (ICU) Delirium

NCT00704301 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

104

Enrollment

OTHER

Sponsor class

Stopped The study is prematurely terminated due to a safety issue

Conditions

Delirium

Interventions

DRUG: Rivastigmine
DRUG: Placebo

Sponsor

UMC Utrecht

Collaborators

[object Object]
[object Object]
[object Object]